Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
Emory University
Emory University
UNC Lineberger Comprehensive Cancer Center
Karolinska University Hospital
University of Texas Southwestern Medical Center
University of California, Davis
Rutgers, The State University of New Jersey
Second Affiliated Hospital of Nanchang University
Second Affiliated Hospital of Guangzhou Medical University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
State University of New York - Upstate Medical University
Case Comprehensive Cancer Center
Stanford University
Wake Forest University Health Sciences
University of South Carolina
Academisch Ziekenhuis Maastricht
University of California, Davis
University of California, Davis
Wake Forest University Health Sciences
University of Texas Southwestern Medical Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Case Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
University of Oxford
University of Michigan Rogel Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of California, Davis
Second Xiangya Hospital of Central South University
Case Comprehensive Cancer Center
Washington University School of Medicine
University of Michigan Rogel Cancer Center
Massachusetts General Hospital
Toronto Sunnybrook Regional Cancer Centre